Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
Carson R. Reynolds, Son Tran, Mohit Jain, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 196-196
Open Access | Times Cited: 24

Showing 24 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 476
Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 75
Exosomes: A potential tool for immunotherapy of ovarian cancer
Xiangjin Gong, Hao Chi, Dorothee Franziska Strohmer, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 58
Engineering nanomaterials for glioblastoma nanovaccination
Fatima Hameedat, Bárbara B. Mendes, João Conniot, et al.
Nature Reviews Materials (2024) Vol. 9, Iss. 9, pp. 628-642
Closed Access | Times Cited: 18
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 37
Tailoring Nanovectors for Optimal Neoantigen Vaccine Efficacy
Youshi Zheng, Binghe Wang, Zhixiong Cai, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Neoantigen vaccines: advancing personalized cancer immunotherapy
Alaa A. A. Aljabali, Yassmen Hamzat, Alaa Alqudah, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Cancer Nanovaccines: Mechanisms, Design Principles, and Clinical Translation
Gabriel de Camargo Zaccariotto, Maria Julia Bistaffa, Angelica Maria Mazuera Zapata, et al.
ACS Nano (2025)
Open Access
In Silico Design of CT26 Polytope and its Surface Display by ClearColi™-Derived Outer Membrane Vesicles as a Cancer Vaccine Candidate Against Colon Carcinoma
Elham Sharif, Navid Nezafat, Fatemeh Maghsood Ahmadi, et al.
Applied Biochemistry and Biotechnology (2024)
Closed Access | Times Cited: 2
Prospects and challenges of neoantigen applications in oncology
Ranran Shi, Ling Ran, Yuan Tian, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113329-113329
Closed Access | Times Cited: 2
Polyethyleneimine-based immunoadjuvants for designing cancer vaccines
Xi Yang, Yuanfeng Wei, Lingnan Zheng, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 40, pp. 8166-8180
Closed Access | Times Cited: 11
Engineering cancer cell membranes with endogenously upregulated HSP70 as a reinforced antigenic repertoire for the construction of material-free prophylactic cancer vaccines
Jing‐Jie Ye, Peng Bao, Kai Deng, et al.
Acta Biomaterialia (2023) Vol. 174, pp. 386-399
Open Access | Times Cited: 5
The Promise of Immunotherapeutics and Vaccines in the Treatment of Cancer
Amitabh Gaur, Narendra Chirmule
(2024), pp. 1209-1251
Closed Access | Times Cited: 1
Nano-Vaccines: Opportunities and Challenges in Biomaterial-Based Vaccine Delivery
Baranya Murugan, Suresh Sagadevan
(2024), pp. 101-116
Closed Access | Times Cited: 1
Material informatics-driven insights into brain cancer nanocarriers: A bibliometric comparison of PLGA vs. liposomes
Brilly Andro Makalew, Syauqi Abdurrahman Abrori
OpenNano (2024) Vol. 21, pp. 100225-100225
Closed Access | Times Cited: 1
How Far Have We Developed Antibody–Drug Conjugate for the Treatment of Cancer?
Yu Jun Lim, Pei Sze Clarissa Lau, S Low, et al.
Drugs and Drug Candidates (2023) Vol. 2, Iss. 2, pp. 377-421
Open Access | Times Cited: 3
ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine
Sehui Kim, Yeji Park, Jeonghun Kim, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1503-1503
Open Access | Times Cited: 3
The Promise of Immunotherapeutics and Vaccines in the Treatment of Cancer
Amitabh Gaur, Narendra Chirmule
(2023), pp. 1-43
Closed Access | Times Cited: 2
ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine
Sehui Kim, Yeji Park, Jeong Hun Kim, et al.
(2023)
Open Access | Times Cited: 2
Immunotherapy of Solid Tumors Based on Neoantigen Vaccines
Elahe Aleebrahim‐Dehkordi, Amir Ghaffari Jolfayi, Nima Rezaei
Springer eBooks (2024), pp. 1-19
Closed Access
Cancer Immunotherapies Ignited by a Thorough Machine Learning‐Based Selection of Neoantigens
Sebastian Jurczak, Maksym Druchok
Advanced Biology (2024) Vol. 8, Iss. 10
Closed Access
Exploring the Potential of Neoantigen-Targeted Immunotherapies in Rare Cancers
Amir Ghaffari Jolfayi, Zahra Taheri, Soroush Khojasteh-Kaffash, et al.
Springer eBooks (2024), pp. 1-32
Closed Access
Technological aspects of creating neopeptide vaccines
М. В. Дмитриева, М. А. Барышникова, О. Л. Орлова, et al.
Russian Journal of Biotherapy (2022) Vol. 21, Iss. 4, pp. 10-21
Open Access | Times Cited: 1
Approaches to the development of the dendritic cell and neoantigen-based antitumor vaccines
NA Bugaev-Makarovskiy, PV Ershov, A A Volkova, et al.
Medicine of Extreme Situations (2023), Iss. 2023(2)
Open Access
Page 1

Scroll to top